Table 1.
Clinical and pathological characterization of HCMV- versus HCMV+ IBC patients.
| Characteristic | HCMV-(N = 9) | HCMV+(N = 19) | P value |
|---|---|---|---|
| Age [year] | |||
| Range Mean ± SD |
33-75 44.9 ± 12.4 |
33-70 49.4 ± 9.8 |
0.292 a |
| Tumor Size [cm] | |||
| Mean ± SD ≤4 >4 |
6.1 ± 2.9 4 (44.4%) 5 (55.6%) |
5.82 ± 2.4 8 (42%) 11 (58%) |
0.602 b |
| Tumor grade | |||
| G1 G2 G3 G4 |
0 (0%) 6 (66.7%) 2 (22.2%) 1 (11.1%) |
0 (0%) 14 (73.7%) 5 (26.3%) 0 (0%) |
0.334 b |
| Axillary Lymph Node Metastasis | |||
| Negative Positive |
1 (11.1%) 8 (88.9%) |
4 (21.1%) 15 (78.9%) |
0.473 b |
| Lymphovascular invasion | |||
| Negative Positive |
5 (55.6%) 4 (44.4%) |
2 (10.5%) 17 (89.5%) |
0.021*b |
| ER | |||
| Negative Positive |
6 (66.7%) 3 (33.3%) |
12 (63.2%) 7 (36.8%) |
0.601 b |
| PR | |||
| Negative Positive |
6 (66.7%) 3 (33.3%) |
11 (57.9%) 8 (42.1%) |
0.493 b |
| HER-2 | |||
| Negative Positive |
7 (77.8%) 2 (22.2%) |
11 (57.9%) 8 (42.1%) |
0.278 b |
| Neoadjuvant Chemotherapy | |||
| Not received Received |
4 (44.4%) 5 (55.6%) |
7 (36.8%) 12 (63.2%) |
0.507 b |
Data are reported as means ± SD.
a
Student’s t-test.
b
Chi-square test.
*Significant P value (p< 0.05).